AI-generated summary
The authors studied 30 hematopoietic stem cell transplant patients who received a one-week extraoral photobiomodulation protocol to prevent oral mucositis. They report it was well tolerated and that mucositis outcomes and pain were similar to their earlier two-week extraoral and intraoral protocols. The findings are from a small single-group comparison with earlier groups.
- Participants
- 30
- Who or what was studied
- Patients undergoing autologous or allogeneic hematopoietic stem cell transplantation
- Limits stated in the abstract
- The abstract describes a small sample and comparison with previous groups rather than a randomized control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 1W, 2W
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, GRADE, Visual analogue scale. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.